PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Injectable hydrogel electrodes open door to a novel painless treatment regimen for arrhythmia

Injectable hydrogel electrodes open door to a novel painless treatment regimen for arrhythmia
2024-01-09
(Press-News.org) HOUSTON (Jan 9, 2024)— A breakthrough study led by Dr. Mehdi Razavi at The Texas Heart Institute (THI), in collaboration with a biomedical engineering team of The University of Texas at Austin (UT Austin) Cockrell School of Engineering led by Dr. Elizabeth Cosgriff-Hernandez, sets the foundation of a ground-breaking treatment regimen for treating ventricular arrhythmia.  Their study published in Nature Communications demonstrates the design and feasibility of a new hydrogel-based pacing modality.

The urgent need for an effective therapeutic regimen for ventricular arrhythmia inspired THI's Electrophysiology Clinical Research & Innovations (EPCRI) team, led by its director, Dr. Razavi, to partner with Dr. Cosgriff-Hernandez and her UT Austin Biomedical Engineering (UT Austin BME) team to co-develop an innovative strategy that addresses the pathophysiology of re-entrant arrhythmia.

Ventricular arrhythmia, which occurs in the lower chambers of the heart or ventricles, is the leading cause of sudden cardiac death in the United States. When heart rhythm abnormality occurs in a self-sustained manner, it is called re-entrant arrhythmia, which is usually fatal.

“Re-entry occurs mainly from delayed conduction in scarred heart tissues, usually after coronary artery occlusion during a heart attack, which can be corrected by enabling pacing in these regions,” said Dr. Razavi, a practicing cardiologist and cardiac electrophysiologist. “These hydrogels then can access the scarred tissue, thereby enabling direct pacing of the otherwise inaccessible regions of the heart.”

Given hydrogels' biostability, biocompatibility, tunable properties, and the ease of incorporating electrical conductivity, the scientists are exploring them as potential electrodes that can be easily delivered inside coronary veins.  A clinical advantage of the unique system is that ischemia can be avoided by delivering the hydrogel using the veins.

The researchers successfully deployed the innovative hydrogel technology through minimally invasive catheter delivery in a pig model.

“The hydrogels have significant conductive properties that enable simultaneous pacing from multiple sites along the length of the hydrogel and create a conduction highway similar to those in Purkinje fibers,” according to Dr. Cosgriff-Hernandez.

Today, arrhythmia is treatable with medicines and procedures that control the irregular rhythms. The current anti-arrhythmic drugs on the market are not always effective; although the drugs slow the conduction velocity, they facilitate re-entry arrhythmia. Moreover, these drugs can be toxic and can lead to the destruction of tissues near the diseased regions of the heart. Even with the widely used interventional ablation therapies, arrhythmia recurs in a significant proportion of patients. None of these procedures address the mechanism of re-entry.

Cardiac defibrillators implanted to compensate for the shortfalls in the current therapy options are painful when delivering electric shocks to restore heart rhythm and can severely deteriorate the patient’s quality of life. If left untreated, arrhythmia can damage the heart, brain, or other organs, leading to stroke or cardiac arrest, during which the heart suddenly and unexpectedly stops beating.

“When injected into target vessels, the conductive hydrogel conforms to the patient’s vessel morphology. Adding a traditional pacemaker to this gel allows for pacing that resembles the native conduction in the heart – effectively mimicking the native electrical rhythm of the heart – and extinguishes the cause for arrhythmia, providing painless defibrillation,” added Dr. Cosgriff-Hernandez.

The work demonstrates for the first time the ability to confer direct electrical stimulation of the native and scarred mid-myocardium through injectable hydrogel electrodes as a pacing modality.

With minimally invasive catheter delivery and standard pacemaker technologies, this study indicates the feasibility of a novel pacing modality that resembles native conduction, potentially eliminating lethal re-entrant arrhythmia and providing painless defibrillation, which can be successfully adopted in a clinical workflow.

The scientific advance is significant considering pain management is highly relevant to overall wellness for patients with heart, lung, and blood diseases. Such innovation in painless defibrillation and preventing arrhythmia could revolutionize cardiac rhythm management.

Funding was provided by the National Heart, Lung, and Blood Institute of the National Institutes of Health (R01 HL162741); Ford Pre-Doctoral Fellowship, administered by the National Academy of Science, Engineering and Medicine; Ford Dissertation Fellowship, administered by the National Academy of Science, Engineering and Medicine; Office of Vice President for Research, The University of Texas at Austin; The Roderick D. MacDonald Research Fund Award 19RDM004; and The Sultan Qaboos Chair in Cardiology at the St. Luke’s Foundation.

The content of this research is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

Rodriguez-Rivera, G.J., Post, A., John, M., Buchan, S., Bernard, D., Razavi, M., Cosgriff-Hernandez, E. Injectable hydrogel electrodes as conduction highways to restore native pacing. Nat Commun 15, 64 (2024). doi: 10.1038/s41467-023-44419-0

 

###

About The Texas Heart Institute

The Texas Heart Institute (THI) is an independent, nonprofit organization with the mission of improving cardiovascular health today through trailblazing research, thought leadership, education, and patient care. Located within the Texas Medical Center in Houston, Texas, and founded in 1962 by renowned cardiac surgeon Dr. Denton Cooley, THI performed the first successful heart transplant and total artificial heart implant in the United States. Since then, its physicians and surgeons have remained recognized as worldwide leaders in diagnosing and treating even the most complex cardiovascular conditions. Research programs at THI continue pushing cardiovascular science's boundaries by translating laboratory discovery into patient care. THI has been ranked among the top cardiovascular centers in the United States by US News & World Report for over 30 years. www.texasheart.org
@texasheartinstitute

 

About The University of Texas at Austin

The University of Texas at Austin (UTA), founded in 1883, ranks among the 40 best universities in the world. The university supports some 52,000 diverse students, 3,000 teaching faculty, and top national programs across 19 colleges and schools. Amid the backdrop of Austin, Texas, a city recognized for its creative and entrepreneurial spirit, the university provides a place to explore countless opportunities for tomorrow's artists, scientists, athletes, doctors, entrepreneurs, and engineers. The mission of UTA is to achieve excellence in the interrelated areas of undergraduate education, graduate education, research, and public service. The university provides superior and comprehensive educational opportunities at the baccalaureate through doctoral and special professional academic levels. The university contributes to the advancement of society through research, creative activity, scholarly inquiry, and the development and dissemination of new knowledge, including the commercialization of its discoveries. www.utexas.edu

 

 

END

[Attachments] See images for this press release:
Injectable hydrogel electrodes open door to a novel painless treatment regimen for arrhythmia Injectable hydrogel electrodes open door to a novel painless treatment regimen for arrhythmia 2 Injectable hydrogel electrodes open door to a novel painless treatment regimen for arrhythmia 3

ELSE PRESS RELEASES FROM THIS DATE:

Inspired by Greek mythology, this potential drug shows promise for vanquishing Parkinson’s RNA in early studies

Inspired by Greek mythology, this potential drug shows promise for vanquishing Parkinson’s RNA in early studies
2024-01-09
JUPITER, Fla. — Like the Greek mythological beast with a snake’s tail and two ferocious heads, a potential Parkinson’s medicine created in the lab of chemist Matthew Disney, Ph.D., is also a type of chimera bearing two heads. One seeks out a key piece of Parkinson’s-causing RNA, while the other goads the cell to chop it to pieces for recycling. The research is described in the Jan. 9 issue of the Proceedings of the National Academy of Sciences, or PNAS. Parkinson’s is a frustrating and all too common disease. Slowly, people with Parkinson’s lose brain cells and other neurons needed to make the neurotransmitter dopamine. This progressive ...

Plant warfare: the crucial function of Nrc proteins in tomato defense mechanisms

2024-01-09
In the fascinating world of plant biology, an innovative study recently featured on the cover of The Plant Journal has been turning heads. The research delves into the intricate defense mechanisms of tomatoes against the notorious bacterial pathogen, Pseudomonas syringae pv. tomato (Pst). It's a classic tale of nature's arms race: as pathogens evolve to outsmart plant defenses, plants counter with more sophisticated immune responses. The study is based on research conducted by scientists in Dr. Greg Martin’s lab ...

NASA’s Webb finds signs of possible aurorae on isolated brown dwarf

NASA’s Webb finds signs of possible aurorae on isolated brown dwarf
2024-01-09
Astronomers using NASA’s James Webb Space Telescope have found a brown dwarf (an object more massive than Jupiter but smaller than a star) with infrared emission from methane, likely due to energy in its upper atmosphere. This is an unexpected discovery because the brown dwarf, W1935, is cold and lacks a host star; therefore, there is no obvious source for the upper atmosphere energy. The team speculates that the methane emission may be due to processes generating aurorae. These findings are being presented at the 243rd meeting of the American Astronomical Society in New Orleans. To help explain the mystery of the infrared ...

Meagan Brem and team receive grant to study alcohol-fueled acts of violence among intimate partners

Meagan Brem and team receive grant to study alcohol-fueled acts of violence among intimate partners
2024-01-09
Beer pong. Quarters. Flip cup. The drinking games college students play can seem like an alcohol-laced version of intramural sports. When college-aged drinkers imbibe too heavily, the risk for physically harming a romantic partner rises considerably. What if there was a way for heavy drinkers to monitor their alcoholic intake and blood-alcohol levels in real time, before an intimate situation cascades into physical violence? Or, as Virginia Tech researcher and assistant professor of psychology Meagan Brem put it: “If we can identify ...

Unlocking the secrets of a "hot Saturn" and its spotted star

Unlocking the secrets of a hot Saturn and its spotted star
2024-01-09
Led by researchers from Université de Montréal's Trottier Institute for Research on Exoplanets (iREx), a team of astronomers has harnessed the power of the revolutionary James Webb Space Webb Telescope (JWST) to study the "hot Saturn" exoplanet HAT-P-18 b. Their findings, published last month in the journal Monthly Notices of the Royal Astronomical Society, paint a complete picture of the HAT-P-18 b's atmosphere while exploring the great challenge of distinguishing its atmospheric signals from the activity of its star. HAT-P-18 b is located over 500 light-years away ...

RSV shown to infect nerve cells, cause inflammation and damage

2024-01-09
Respiratory syncytial virus (RSV), a common infection in children and senior adults, can also infect nerve cells and trigger inflammation leading to nerve damage, according to a new Tulane University study. RSV can cause mild symptoms such as coughing, sneezing and fever or lead to more severe conditions such as pneumonia or bronchiolitis. But since the disease was first discovered in 1956, it has been thought to only infect the respiratory tract. This study, published in The Journal of Infectious Diseases, is the first to prove that RSV can penetrate nerve cells and may provide the ...

A common marker of neurological diseases may play role in healthy brains

2024-01-09
https://www.ninds.nih.gov/news-events/press-releases/common-marker-neurological-diseases-may-play-role-healthy-brainsResearchers have discovered that a protein called phosphorylated α-synuclein, which is associated with several neurodegenerative diseases such as Parkinson’s disease and Lewy body dementia, is also involved in the normal processes of how neurons communicate with each other in a healthy brain. The research, published in Neuron, was funded in part by the National Institute of Neurological Disorders and Stroke (NINDS), a part of the National Institutes of Health.   Phosphorylation is a process where a phosphate ...

ChatGPT poem regurgitation raises ethical questions

2024-01-09
ITHACA, N.Y. – Ask ChatGPT to find a well-known poem and it will probably regurgitate the entire text verbatim – regardless of copyright law – according to a new study by Cornell University researchers. The study showed that ChatGPT was capable of “memorizing” poems, especially famous ones commonly found online. The findings pose ethical questions about how ChatGPT and other proprietary artificial intelligence models are trained – likely using data scraped from the internet, researchers said. “It’s generally not good for large language models to memorize large chunks of text, in part because it’s a privacy concern,” ...

Sickle cell raises COVID-19 risk, but vaccination lags

2024-01-09
Despite the fact that people with sickle cell disease have a much higher risk of serious illness or death if they develop COVID-19, a new study shows they’re also much less likely than those without sickle cell disease to have gotten vaccinated against coronavirus.  Completion of the initial COVID-19 vaccination series was nearly two times lower for adults with sickle cell disease as others their age, the analysis of data in Michigan shows.  In in teens and children over 5, who overall have lower rates of COVID-19 vaccination, those with sickle cell disease were far less likely than other young people to have gotten their doses by summer 2022, the analysis ...

Brookline Housing Authority partners with Hebrew SeniorLife for health and social services in senior housing

2024-01-09
The Brookline Housing Authority (BHA) has partnered with Hebrew SeniorLife, New England’s largest nonprofit provider of senior health care and living communities, and the only senior care organization affiliated with Harvard Medical School, to provide community life services including resident services, fitness, social programming, and nursing in BHA’s senior housing sites. Hebrew SeniorLife brings to the BHA its model of housing with services called the Right Care, Right Place, Right Time (R3) program. This model uses a preventive approach to resident services, focused on one-on-one relationship building, community-wide ...

LAST 30 PRESS RELEASES:

Study identifies potential novel drug to treat tuberculosis

UTEP study: Zooplankton go “Eew!” to cleaning feces contaminated water

FAU awarded $10M to train people with disabilities for in-demand tech jobs

Plants have a backup plan

Logic with light

Wastewater bacteria can breakdown plastic for food

Researchers study 3D printing tungsten parts for extreme conditions in nuclear reactors

Promising ‘first’ in Alzheimer’s drug development

Quantum researchers come up with a recipe that could accelerate drug development

Experts publish the latest guide for systematic reviews of preclinical research

Oyster reefs once thrived along Europe’s coasts – now they’re gone

Decades-long research reveals new understanding of how climate change may impact caches of Arctic soil carbon

How Soviet legacy has influenced foreign policy in Georgia and Ukraine

Robin Dunbar: Pioneering evolutionary psychologist redefines human social networks

Balancing health: diabetes and obesity increase risk of liver cancer relapse

Duke-NUS launches new pictograms to clarify medication instructions, enhancing patient care

Chiral nanocomposite for highly selective dual-mode sensing and bioimaging of hydrogen sulfide

UCLA researchers develop new risk scoring system to account for role of chronic illness in post-surgery mortality

Mount Sinai BioDesign expands industry collaborations to expedite and enhance the development of innovative surgical technologies

Study reveals limits of using land surface temperature to explain heat hazards in Miami-Dade County

The Lancet Public Health: Accelerating actions to eliminate tobacco smoking could help increase life expectancy and prevent millions of premature deaths by 2050, modelling study suggests

The Lancet Public Health: Banning tobacco sales among young people could prevent 1.2 million lung cancer deaths, global modelling study suggests

One million people who never regularly smoked now vape in England

Methane emissions from dairy farms higher than thought - but conversion could reduce emissions

Early foster care gave poor women power, 17th-century records reveal

Unpacking polar sea ice

U of M Medical School receives $3.2M to study drivers of chronic low back pain

UT Health San Antonio School of Nursing’s Caring for the Caregiver program earns national award

People infer the past better than the future, study finds

Sexual and gender minorities more likely to experience life dissatisfaction, isolation, stress

[Press-News.org] Injectable hydrogel electrodes open door to a novel painless treatment regimen for arrhythmia